JBT Marel surges as Q1 adjusted EPS beats and 2026 guidance holds

JBTMJBTM

JBT Marel shares are jumping after first-quarter 2026 results showed revenue of $936 million and adjusted EPS of $1.58, beating consensus estimates. The company reiterated full-year 2026 guidance, reported $1.07 billion in orders, and generated $119 million in operating cash flow while deleveraging to 2.6x.

1) What’s driving the stock today

JBT Marel (JBTM) is rallying after reporting first-quarter 2026 earnings that came in ahead of expectations and keeping its full-year outlook intact. The quarter featured revenue of $936 million and adjusted EPS of $1.58, which exceeded the Street’s consensus estimate, helping reset confidence in the post-combination earnings trajectory. (ir.jbtmarel.com)

2) Orders, backlog, and demand signals

Investors are also responding to stronger demand indicators: inbound orders totaled $1.07 billion in the quarter and backlog ended at $1.49 billion, supporting a book-to-bill above 1.0 and signaling healthier forward workload. Those order metrics matter because the stock’s move suggests the market is prioritizing visibility and conversion into 2026 revenue as integration work continues. (ir.jbtmarel.com)

3) Cash flow, leverage, and what changes the narrative

Operational execution showed up in cash generation and balance sheet progress. Operating cash flow was $119 million and management pointed to ongoing operational improvement and deleveraging, with leverage cited at 2.6x—data that can reduce concerns about integration costs and financing overhang while supporting flexibility for continued restructuring and synergy capture. (ir.jbtmarel.com)

4) Guidance check and the next catalyst

The company reiterated full-year 2026 guidance, including adjusted EPS of $8.00–$8.50 and revenue around $4.0–$4.1 billion, which helps explain why the market reaction is outsized despite the stock’s already elevated starting point. The next test for the rally will be whether subsequent quarters sustain order momentum and margin delivery consistent with the reiterated outlook. (marketbeat.com)